The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Strange - Q2 hasn't ended and Q3 hasn't started???
Thursday, 20 June, 2:00pm
Poolbeg Pharma Chief Executive Officer, Jeremy Skillington and Chief Business Officer, David Allmond will present their results for Q2 and Q3, followed by a Q&A session.
To attend, register here: https://bit.ly/POLB_Q2-Q3_investor_webinar
POLB001 partnership deal must surely only be a whisker away, probably just dotting the i's and crossing the T's I right now, could well be a muti bagger I reckon !! 40p by the time I go on my summer hols in July !!! All good things come to those who wait !!!
300k purchase at 13.0p and a 600k share purchase above the ask at 13.35p...something brewing?
Big news coming on Polb-001 I wonder or something else?...Price is creeping back up again after last month's spike to nearly 16p? Investor event going on this week.
Nice summary of the status quo. POLB-001 really looks like it could be a game-changer and has the chance to become a standard adjunctive therapy for immunotherapy with high CRS risk.
Try this link as they didn't like the directors one.
https://twitter.com/PoolbegPharma/status/1792833447284887711
GLA
https://www.***************************/poolbeg-pharma-well-positioned-for-success-with-ceo-jeremy-skillington/4121157833
Follower of what exactly
Hi there Moniman. Good advice !!
Hallsworthy also added to the Green bin yet another Totally Deluded follower.
Why does it smell like a placing exactly? Or was that a lazy throwaway remark. It's down because it went up too fast, simple as that. rsi too high, macd just crossed negative, stoch on a sharp decline. 11.75 is pretty much a certainty, with 10 the next obvious level of support then 8 after that. I don't expect it to hit that low, but if news doesn't come before year end, that could easily happy. You pays your money, you takes your chance
@Spuddy just filter them, I saw 3 green boxes in quick succession, they're annoyed cause they've been given a taste of their own trolling medicine on their favourite spamming boards.
Of course there will be no fund raise before share price rises 200/300 % and perhaps prior to Nasdaq listing. 12m sterling is in the bank and prudently managed. Polb-001 is becoming more valuable every day. I get the sneaky suspicion that Polbeg are looking for orphan status for Polb-001. If granted it would make it even more valuable. Obviously before concluding a deal you want all details relating to Polb-001 denomination resolved plus extensive IP patenting in place. So whilst the shorters play their games the wise investor should hold and be patient. We will be rewarded very nicely !!!
Have they spent the £12m?
@ 10p
Smells a like a placing enroute.
Ah ha - Looks like a worked sell of 600k+. Hopefully now they are out, we can continue upward!?
Your 13p has been blown away. Not even much buying in the 12s. It's all one way down.
Strange the 30% movement last week (I'm not complaining btw!) but for then nothing of note to be announced, seems a bit strange. Hope we at least stay around the 13p - 13.5p mark.
Sorry I thought something new. This was rolled out at the Web event and the behcets is a cut and paste from his last venture partner.
Scroll down to company presentations just click on it it’s all there Peter.
Where is this presentation please tiger, normally I can find stuff, this I can't.
New presentation out featuring Behcets disease.
Good luck to all here to and have a good weekend to :)